Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 837, Issue -, Pages 1-7Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2018.08.030
Keywords
Canonical transient receptor potential receptor 3; Atrial fibrillation; Cardiac remodeling; Ca2+ influx
Categories
Funding
- National Natural Science Foundation of China [81200132]
- Natural Science Foundation of Jiangxi [20152ACB20025]
- Project of Science and Technology of Jiangxi [20151BBG70166]
Ask authors/readers for more resources
The pathogenesis of atrial fibrillation (AF) is largely dependent on structural remodeling and electrical reconfiguration, which in turn drive localized fibrosis. Canonical transient receptor potential 3 (TRPC3) channel is indispensable regulator of fibrosis development, promoting fibroblasts to transition into myofibroblasts via intracellular Ca2+ overload. TRPC3 is a non-voltage gated, non-selective cation channel that regulates the permeability of the cell to Ca2+. When subjected to various external physical and chemical stimuli, such as angiotensin II (AngII), mechanical stretch, hypoxia, or oxidative stress, TRPC3 coordinates with downstream signal transduction pathways to alter gene expression and thereby regulate a number of distinct pathological patterns and mechanisms. This review will focus on how TRPC3 affects AF pathogenesis by exploring the underlying mechanisms governing fibrosis associated with particular signaling proteins, ultimately highlighting the characteristics of TPRC3 that mark it as a novel therapeutic target for AF alleviation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available